iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.
Saved in:
| Title: | iRHOM2 is a critical pathogenic mediator of inflammatory arthritis. |
|---|---|
| Authors: | Issuree PD; Arthritis and Tissue Degeneration Program, Autoimmunity and Inflammation Program, Hospital for Special Surgery, Weill Cornell University, New York, New York, USA., Maretzky T, McIlwain DR, Monette S, Qing X, Lang PA, Swendeman SL, Park-Min KH, Binder N, Kalliolias GD, Yarilina A, Horiuchi K, Ivashkiv LB, Mak TW, Salmon JE, Blobel CP |
| Source: | The Journal of clinical investigation [J Clin Invest] 2013 Feb; Vol. 123 (2), pp. 928-32. Date of Electronic Publication: 2013 Jan 25. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
